Supreme Court Opinions

Sripetch v. SEC

30 min · 7 de jun de 2026
Portada del episodio Sripetch v. SEC

Descripción

Welcome to Supreme Court Opinions. In this episode, you’ll hear the Court’s opinion in Sripetch v SEC. In this case, the court considered this issue: May the SEC seek equitable disgorgement under 15 U.S.C. §§ 78u(d)(5) and (d)(7) without showing investors suffered pecuniary harm?  The case was decided on June 4, 2026.  The opinion is presented here in its entirety, but with citations omitted. If you appreciate this episode, please subscribe. Thank you.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Supreme Court Opinions!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

257 episodios

episode Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. artwork

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

Welcome to Supreme Court Opinions. In this episode, you’ll hear the Court’s opinion in Hikma Pharmaceuticals USA Inc. v Amarin Pharma, Inc. In this case, the court considered these issues. 1. When a generic drug manufacturer excludes a patented use from its label, can it still be liable for inducing infringement if it calls its product a “generic version” of the brand-name drug and cites publicly available information about the brand-name drug’s sales? 2. Can a patent infringement complaint survive dismissal if it does not allege that the defendant made any statement specifically instructing or encouraging the patented use? The case was decided on June 4, 2026.  The opinion is presented here in its entirety, but with citations omitted. If you appreciate this episode, please subscribe. Thank you.

7 de jun de 202617 min